Lightship’s Post

What a great opportunity to meet and learn at #DPHARM! Thanks in particular to Henry Wei, Syed Waseem, David Apfel, Shameer Khader, Ph.D, MPH, Mohammed Ali who participated in this fantastic panel. Read my recap below! https://lnkd.in/ekXXE_wM #AI #ClinicalTrials

🚀 Meet Chuck Grohoski from OnPoint Clinical at DPharm 2024! 🚀 Is your clinical operations team struggling with overpriced, underperforming talent that’s delaying timelines and straining budgets? OnPoint is here to disrupt that narrative. We deliver senior-level talent that streamlines workflows, reduces turnover, and helps you bring life-saving drugs to market sooner—all while cutting costs of running your studies by up to 30%. Catch up with Chuck Grohoski Chuck Grohoski, our VP of Sales, at the conference today to learn how we can help you hit your clinical milestones faster. 🌟 #ClinicalResearch #FSP #DPharm2024 #OnPointSolutions

🚀 Meet Chuck Grohoski from OnPoint Clinical at DPharm 2024! 🚀 Is your clinical operations team struggling with overpriced, underperforming talent that’s delaying timelines and straining budgets? OnPoint is here to disrupt that narrative. We deliver senior-level talent that streamlines workflows, reduces turnover, and helps you bring life-saving drugs to market sooner—all while cutting costs of running your studies by up to 30%. Catch up with Chuck Grohoski Chuck Grohoski, our VP of Sales, at the conference today to learn how we can help you hit your clinical milestones faster. 🌟 #ClinicalResearch #FSP #DPharm2024 #OnPointSolutions

The cat is out of the bag. Yes, James Harper and Paul Simms were behind Callr all along and ‘fortunately’ it does not actually exist… We had a ‘blast’ creating this industry parody and we do apologise if we actually got your hopes up with Callr… While it seems we picked up plenty of laughs, several people commented on how scarily close this ‘software’ is to reality. That was part of the reason that we, Callr, came to bear. We felt that it would take something this ridiculous to shine a light on the direction that rep to HCP engagement is headed in the pharma industry. While Callr isn’t coming to you soon, our next live Digital Pharma: Unlocked event certainly is! Our expert panel will be discussing the role of the rep and what it is like to sell and be sold to. Come and join the debate! For more information on how to register for this event, follow the link in our comments to our meet-up page. Please register via our meet-up page and we look forward to seeing you in person (or virtually if you cannot make it). #pharma #pharmasales #pharmamarketing

Exciting news! Join us at Pharma Forum March 24-27, in Tampa, Florida. Pharma Forum is the premier conference for meeting and event professionals shaping the future of medical meetings and compliance strategies. If you're headed to Pharma Forum, stop by and visit us at booth number 303. We can't wait to connect with you! #PharmaForum #InnovateComplyConnect #MedicalMeetings #TampaFlorida #Booth303 #SeeYouThere #L!VE

🚨 Reminder that if you're going to #DPHARM tomorrow, you can see us at Booth 65! Book a meeting slot in advance at https://hubs.li/Q02PXWV_0 And remember to set your phasers to STUNNED for a major announcement... 🤯 #Teckro #ClinicalResearch #ClinicalTrials #ClinicalTrialTech #MedTech #SitePerformance #SiteEngagement #StudyRecruitment #DPHARM2024 DPHARM: Disruptive Innovations to Modernize Clinical Research

In a recent interview with Clinical Trials Arena, Myonex's Stephen Finore discussed a key issue affecting patient trial access: the burden of leveraging patient insurance. For many underinsured patients, the high costs of medications and insurance prevent access to standard-of-care medications. These barriers disproportionately impact diverse groups, limit patient access, and hinder the diversity needed to make trials truly representative. Reducing these hurdles is crucial for allowing more patients to participate and fostering more inclusive, impactful trials. Learn more about how we work with our clients to improve patient access and trial diversity: ➡ https://bit.ly/4gXIqZh. #ClinicalTrialSupply #DEI #DEIInClinicalTrials #Myonex #PatientSolutions

Increasing demand for specialized medications and personalized patient care are driving rapid growth in the specialty pharmacy space. Join this week’s Office Hours guest Derek Taylor, Senior Director, Client Services, Infinx, as he provides insights and tools necessary for success in the burgeoning world of specialty pharma. Attendees can expect to: ✅ Understand the current landscape and future trends of the specialty pharma industry. ✅ Learn about the unique resources and support options that are vital for navigating the complexities of specialty pharmacy operations effectively. ✅ Discover the specialized tools, technologies, and strategies that can drive operational excellence and competitive advantage. Whether you're a seasoned professional looking to update your knowledge or new to the specialty pharma field seeking to make your mark, Derek will share the knowledge and strategies needed to excel. Register here: https://hubs.li/Q02mql550 #PatientAccess #RCMAutomation #PriorAuthorization #SpecialtyPharmacy #SpecialtyPharma

Make sure to stop by and learn more about TPS at DPHARM 2024!

Crestview Strategy Vice President Muhammad Ali joined AM900 CHML | Hamilton News discussing the government's approach to rolling out the Pharmacare program and the reasoning behind it. Listen below for his insights: #cdnpoli #pharmacare